Covid-19: Conditional approval for Spikevax vaccine for aged 12 and above


KUALA LUMPUR: The Spikevax Covid-19 vaccine produced by Rovi Pharma Industrial Services in Spain has been given conditional approval in Malaysia for those who are 12-years-old and above, says Tan Sri Dr Noor Hisham Abdullah.

The Health director-general said the decision was made at the 375th Drug Control Authority (DCA) meeting on Thursday (Aug 4).

Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Spikevax , vaccine , Dr Noor Hisham

Next In Nation

Viral video of bloodied woman in Lahat leads to husband's arrest
Teenage boy dies after falling from building in Shah Alam
Water shortage temporarily halted firefighting efforts at forest near Bintulu, says Bomba
Building a more inclusive future in healthcare
Rising need for green energy
Pushbike therapy for kids with health issues
Adult-themed micro dramas played by child actors draw flak
Shifting away from fossil fuels
DBKK urged to let Pulau Gaya folk use new jetty
Ways to trim fuel subsidies

Others Also Read